These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1659961)

  • 1. Renal tubular acidosis, a side effect of treatment with pentavalent antimony.
    Horber FF; Lerut J; Jaeger P
    Clin Nephrol; 1991 Oct; 36(4):213. PubMed ID: 1659961
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal dysfunction in patients of kala azar treated with sodium antimony gluconate.
    Rai US; Kumar H; Kumar U
    J Assoc Physicians India; 1994 May; 42(5):383. PubMed ID: 7829438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic.
    Sundar S; More DK; Singh MK; Singh VP; Sharma S; Makharia A; Kumar PC; Murray HW
    Clin Infect Dis; 2000 Oct; 31(4):1104-7. PubMed ID: 11049798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Indian Kala-azar with pentavalent antimony.
    Domingo P; Ferrer S; Kolle L; Muñoz C; Sambeat MA
    Lancet; 1995 Mar; 345(8949):584-5. PubMed ID: 7776793
    [No Abstract]   [Full Text] [Related]  

  • 5. ECG changes in prolonged treatment of kala-azar with antimony compounds.
    Pandey AK; Kumar M; Thakur CP
    J Assoc Physicians India; 1988 Jun; 36(6):398-9. PubMed ID: 2846508
    [No Abstract]   [Full Text] [Related]  

  • 6. Antimony-induced cerebellar ataxia.
    Khalil EA; Ahmed AE; Musa AM; Hussein MH
    Saudi Med J; 2006 Jan; 27(1):90-2. PubMed ID: 16432602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antimony content of the thyroid of man and animals undergoing visceral leishmaniasis treatment with the organic compound of antimony, stibogluconate sodium].
    Fuzaĭlov IuM
    Med Parazitol (Mosk); 1982; 51(1):62-5. PubMed ID: 6278277
    [No Abstract]   [Full Text] [Related]  

  • 8. Sodium stibogluconate.
    Shrestha NK
    Clin Infect Dis; 2006 Nov; 43(10):1371-2. PubMed ID: 17051510
    [No Abstract]   [Full Text] [Related]  

  • 9. Complications of kala azar and its treatment in Kenya.
    Chunge CN; Gachihi G; Chulay JD; Spencer HC
    East Afr Med J; 1984 Feb; 61(2):120-7. PubMed ID: 6088210
    [No Abstract]   [Full Text] [Related]  

  • 10. Conduction defect following pentavalent antimony therapy in visceral leishmaniasis.
    Ahasan HA; Chowdhury MA; Azhar MA; Rafiqueuddin AK; Islam F
    Trop Doct; 1997 Jan; 27(1):59-61. PubMed ID: 9030031
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug regimens for visceral leishmaniasis in Mediterranean countries.
    Gradoni L; Soteriadou K; Louzir H; Dakkak A; Toz SO; Jaffe C; Dedet JP; Campino L; Cañavate C; Dujardin JC
    Trop Med Int Health; 2008 Oct; 13(10):1272-6. PubMed ID: 18764817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of visceral leishmaniasis.
    Thakur CP
    J Assoc Physicians India; 1985 May; 33(5):379-80. PubMed ID: 2995305
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypoplasia of bone marrow secondary to sodium antimony gluconate.
    Mallick BK
    J Assoc Physicians India; 1990 Apr; 38(4):310-1. PubMed ID: 2167887
    [No Abstract]   [Full Text] [Related]  

  • 14. Does antimony therapy cause bleeding in kala-azar patients and why?
    Chowdhury MA; Ahasan HA; Azhar MA; Rafiqueuddin AK; Islam MR; Misbahuddin M; Rashid MU
    Trop Doct; 1995 Oct; 25(4):188-9. PubMed ID: 7502336
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of visceral leishmaniasis].
    Bardzhadze BG
    Med Parazitol (Mosk); 1979; 48(6):11-6. PubMed ID: 229392
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of visceral leishmaniasis using sodium stibogluconate in a dose of 15 mg antimony/kg body weight twice daily for 30 days: a preliminary report.
    Chunge CN; Gachihi G; Mugambi M; Chulay JD; Spencer HC
    East Afr Med J; 1984 Jul; 61(7):570-4. PubMed ID: 6100588
    [No Abstract]   [Full Text] [Related]  

  • 17. Short term treatment of visceral leishmaniasis of the Old World with low dose interferon gamma and pentavalent antimony.
    van Lunzen J; Kern P; Schmitz J; Brzoska J; Flessenkämper S; Dietrich M
    Infection; 1993; 21(6):362-6. PubMed ID: 8132364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deaths in visceral leishmaniasis (Kala-azar) during treatment.
    Ahasan HA; Chowdhury MA; Azhar MA; Rafiqueuddin AK; Azad KA
    Med J Malaysia; 1996 Mar; 51(1):29-32. PubMed ID: 10967976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of visceral leishmaniasis.
    Wali JP; Sharma SK; Guleria JS
    J Assoc Physicians India; 1984 Sep; 32(9):813-4. PubMed ID: 6096351
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug-induced ventricular tachycardia in kala-azar.
    Krishnan S; Tuteja A; Gupta HL; Prakash SK
    J Indian Med Assoc; 1987 Feb; 85(2):52-4. PubMed ID: 3039008
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.